The IL-6 contributes to inflammation in all insulin target tissues, including fat, the liver, and muscle, indicating the role of IL-6 in driving obesity and in the pathogenesis of systemic insulin resistance (Rocha and Folco, 2011; El-Kadre and Tinoco, 2013). The gene discussed is INS; the disease is obesity disorder.